Kaiping Xu

Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK)

Smita Jha, Kaiping Xu, Takahiro Maruta et al. · Journal of Neuroimmunology · 2006 · 106 citations

Life Sciences, Biochemistry, Molecular Biology +8

Knockout of Zn Transporters Zip-1 and Zip-3 Attenuates Seizure-Induced CA1 Neurodegeneration

Jing Qian, Kaiping Xu, Jong W. Yoo et al. · Journal of Neuroscience · 2011 · 77 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective Kv7.1 (KCNQ1) potassium channel activator

Margrith E. Mattmann, Haibo Yu, Zhihong Lin et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 71 citations · Full text

Natural Sciences, Medicinal Chemistry, Pharmacology +14

Antioxidants and free radical scavengers do not consistently delay seizure onset in animal models of acute seizures

Kaiping Xu, Janet L. Stringer · Epilepsy & Behavior · 2008 · 41 citations

Medicine, Neurobiology, Neuroscience +12

Discovery of a Series of 2-Phenyl-<i>N</i>-(2-(pyrrolidin-1-yl)phenyl)acetamides as Novel Molecular Switches that Modulate Modes of K_v7.2 (KCNQ2) Channel Pharmacology: Identification of (<i>S</i>)-2-Phenyl-<i>N</i>-(2-(pyrrolidin-1-yl)phenyl)butanamide (ML252) as a Potent, Brain Penetrant K_v7.2 Channel Inhibitor

Yiu‐Yin Cheung, Haibo Yu, Kaiping Xu et al. · Journal of Medicinal Chemistry · 2012 · 29 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17